McGivney GlobalOct 25, 20161 minOncologists, McGivney Weigh in on Value FrameworksPrior to the ICER meeting to review evidence and vote on cost-effectiveness ratings for NSCLC treatments, five prominent oncologists...
McGivney GlobalOct 25, 20162 minComments on the Recent Institute for Clinical and Economic Review (ICER) MeetingI have extensive experience in “real world” policy-setting and decision-making and I am puzzled about the motivations regarding the...
McGivney GlobalJun 16, 20161 minMcGA work on ICER cited by BIOA McGivney Global Advisors op-ed on Oncology Value Metrics and ICER was referenced by the Biotechnology Industry Organization, quoting...
